Locus Pharmaceuticals, Inc.
Records under this name other than the patents Locus Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Locus Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,765,754 | Pyrrolotriazine compounds Lapsed on the fee record Ended Jul 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2022 | From the USPTO record |
| US 7,741,479 | Urea inhibitors of MAP kinases Lapsed on the fee record Ended Jun 22, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 22, 2014 | From the USPTO record |
| US 7,612,200 | Inhibitors of protein kinases Lapsed on the fee record Ended Nov 3, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 3, 2013 | From the USPTO record |
| US 7,504,401 | Anti-cancer agents and uses thereof Lapsed on the fee record Ended Mar 17, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 17, 2013 | From the USPTO record |
| US 7,415,361 | Methods and systems for analyzing and determining ligand-residue interaction Lapsed on the fee record Ended Aug 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2012 | From the USPTO record |
| US 6,182,016 | Molecular classification for property prediction Formerly held Lapsed on the fee record Ended Jan 30, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jan 30, 2009 | From the USPTO record |